Beyond proud to share my first (co-)first author manuscript out today in #Nature, where we describe the inhibition of epithelial-to-mesenchymal transition (#EMT) by pharmacological targeting of netrin-1 (1/23) nature.com/articles/s4158…

Our next "IMPloyable talent" interview features Jelle Jacobs, postdoc in the StarkLab & aspiring #youngPI. Jelle would like to apply his expertise in #generegulation to explore the molecular basis of memory formation. Read on & get in touch! ⬇️ imp.ac.at/career/beyond/…

Exciting news! Our latest research on "Cell type directed design of synthetic enhancers" has been published in nature. We've harnessed deep learning to design enhancers with cell-type specificity. Find our paper here: nature.com/articles/s4158…. Highlights below: [1/n]

A couple of years ago, Sam Altman aimed $180 million at Retro in a bid to see if humans could extend their lives by 10 healthy, vigorous years. Here's an exclusive look at what the company has been up to. bloomberg.com/news/features/…

Happy to announce the first paper of my postdoc in the Treutlein lab! A fun collaboration with Hsiu-Chuan Lin where we investigated how morphogen signaling pathways can be used to increase the diversity of TF-induced neurons. Check the paper here: t.ly/XfJvk!

Very excited to announce our new preprint together with Nikolai Hecker! Dive into our findings on the conserved regulatory codes shaping cell identity across species. 🧬 [1/n] biorxiv.org/content/10.110…

THE LITTLE TECH AGENDA Marc Andreessen & Ben Horowitz July 5, 2024 Little Tech is our term for tech startups, as contrasted to Big Tech incumbents. Little Tech has run independent of politics for our entire careers. But, as the old Soviet joke goes, “You may not be interested

Mario Draghi's new report on EU competitiveness doesn't mince words. "Across different metrics, a wide gap in GDP has opened up between the EU and the US, driven mainly by a more pronounced slowdown in productivity growth in Europe. Europe’s households have paid the price in

Biotech and pharma should have the confidence to generate large (in the order of $10M) structured, high-dimensional datasets across a large number of technical and biological replicates with the explicit intent to feed this data into machine learning models. There is a demand,

Ghibli is out, Akira is in

GoFundMe here: gofundme.com/f/stand-with-k…

What if we could integrate, play with, and control lab hardware as easily as we do software? That’s the vision behind PyLabRobot, an open-source, hardware-agnostic Python SDK building a universal interface for lab automation. I sat down with its creator, Rick Wierenga, to

Awesome and important work!!

One of the greatest movies of all time

This was really fun! I would highly recommend Frontier Tower x Foresight x Seanome events!

Sister Wendy describes Rothko youtube.com/watch?v=v3sPAT…

super excited to announce our collaboration to the world! here’s the backstory: we started with a shared goal of using AI to generate novel discoveries that would be non-trivial for human scientists to make